APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment of PNH

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Treatment of PNH Industry Growth and Trends Forecast to 2032

28 December 202596 pages

Choose your research edition.

Industry ResearchTreatment of PNH Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment of PNH Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Treatment of PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment of PNH Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment of PNH Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Treatment of PNH market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Treatment of PNH include Alexion Pharmaceuticals, Apellis Pharmaceuticals, Samsung Bioepis, Amgen, Roche and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Treatment of PNH market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Treatment of PNH market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Treatment of PNH market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Treatment of PNH.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Treatment of PNH market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Treatment of PNH Market by Company

Alexion Pharmaceuticals

Apellis Pharmaceuticals

Samsung Bioepis

Amgen

Roche

Novartis

Treatment of PNH Segment by Type

Complement Inhibitors

Supportive Care

Others

Treatment of PNH Segment by Application

Hospital

Clinic

Other

Treatment of PNH Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of PNH.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Treatment of PNH manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Treatment of PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Complement Inhibitors Table 2. Major Company of Supportive Care Table 3. Major Company of Others Table 4. Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 6. Global Treatment of PNH Sales Market Share in Volume by Type (2021-2026) Table 7. Global Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 8. Global Treatment of PNH Sales Market Share in Value by Type (2021-2026) Table 9. Global Treatment of PNH Price by Type (2021-2026) & (US$/Unit) Table 10. Global Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 11. Global Treatment of PNH Sales Market Share in Volume by Type (2027-2032) Table 12. Global Treatment of PNH Sales by Type (2027-2032) & (US$ Million) Table 13. Global Treatment of PNH Sales Market Share in Value by Type (2027-2032) Table 14. Global Treatment of PNH Price by Type (2027-2032) & (US$/Unit) Table 15. North America Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 16. North America Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 18. Europe Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 22. Latin America Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Treatment of PNH Sales by Type (2021-2026) & (US$ Million) Table 25. Treatment of PNH Industry Trends Table 26. Treatment of PNH Industry Drivers Table 27. Treatment of PNH Industry Opportunities and Challenges Table 28. Treatment of PNH Industry Restraints Table 29. Global Treatment of PNH Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Treatment of PNH Revenue Market Share by Company (2021-2026) Table 31. Global Treatment of PNH Sales by Company (2021-2026) & (K Units) Table 32. Global Treatment of PNH Sales Share by Company (2021-2026) Table 33. Global Treatment of PNH Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Treatment of PNH Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Treatment of PNH Major Company Production Sites and Headquarters Table 36. Global Treatment of PNH Company, Product Type & Application Table 37. Global Treatment of PNH Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Treatment of PNH by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Treatment of PNH Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Treatment of PNH Sales by Region (2021-2026) & (K Units) Table 42. Global Treatment of PNH Sales Market Share in Volume by Region (2021-2026) Table 43. Global Treatment of PNH Sales by Region (2021-2026) & (US$ Million) Table 44. Global Treatment of PNH Sales Market Share in Value by Region (2021-2026) Table 45. Global Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Treatment of PNH Sales by Region (2027-2032) & (K Units) Table 47. Global Treatment of PNH Sales Market Share in Volume by Region (2027-2032) Table 48. Global Treatment of PNH Sales by Region (2027-2032) & (US$ Million) Table 49. Global Treatment of PNH Sales Market Share in Value by Region (2027-2032) Table 50. Global Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 53. Global Treatment of PNH Sales Market Share in Volume by Application (2021-2026) Table 54. Global Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 55. Global Treatment of PNH Sales Market Share in Value by Application (2021-2026) Table 56. Global Treatment of PNH Price by Application (2021-2026) & (US$/Unit) Table 57. Global Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 58. Global Treatment of PNH Sales Market Share in Volume by Application (2027-2032) Table 59. Global Treatment of PNH Sales by Application (2027-2032) & (US$ Million) Table 60. Global Treatment of PNH Sales Market Share in Value by Application (2027-2032) Table 61. Global Treatment of PNH Price by Application (2027-2032) & (US$/Unit) Table 62. North America Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 63. North America Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 65. Europe Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 69. Latin America Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Treatment of PNH Sales by Application (2021-2026) & (US$ Million) Table 72. Alexion Pharmaceuticals Company Information Table 73. Alexion Pharmaceuticals Business Overview Table 74. Alexion Pharmaceuticals Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Alexion Pharmaceuticals Treatment of PNH Product Portfolio Table 76. Alexion Pharmaceuticals Recent Development Table 77. Apellis Pharmaceuticals Company Information Table 78. Apellis Pharmaceuticals Business Overview Table 79. Apellis Pharmaceuticals Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apellis Pharmaceuticals Treatment of PNH Product Portfolio Table 81. Apellis Pharmaceuticals Recent Development Table 82. Samsung Bioepis Company Information Table 83. Samsung Bioepis Business Overview Table 84. Samsung Bioepis Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Samsung Bioepis Treatment of PNH Product Portfolio Table 86. Samsung Bioepis Recent Development Table 87. Amgen Company Information Table 88. Amgen Business Overview Table 89. Amgen Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Amgen Treatment of PNH Product Portfolio Table 91. Amgen Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Treatment of PNH Product Portfolio Table 96. Roche Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis Treatment of PNH Product Portfolio Table 101. Novartis Recent Development Table 102. North America Treatment of PNH Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 104. North America Treatment of PNH Sales Market Share by Country (2021-2026) Table 105. North America Treatment of PNH Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Treatment of PNH Sales Market Share Forecast by Country (2027-2032) Table 107. North America Treatment of PNH Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Treatment of PNH Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Treatment of PNH Market Share by Country (2021-2026) Table 110. North America Treatment of PNH Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Treatment of PNH Market Share Forecast by Country (2027-2032) Table 112. Europe Treatment of PNH Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 114. Europe Treatment of PNH Sales Market Share by Country (2021-2026) Table 115. Europe Treatment of PNH Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Treatment of PNH Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Treatment of PNH Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Treatment of PNH Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Treatment of PNH Market Share by Country (2021-2026) Table 120. Europe Treatment of PNH Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Treatment of PNH Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Treatment of PNH Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Treatment of PNH Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Treatment of PNH Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Treatment of PNH Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Treatment of PNH Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Treatment of PNH Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Treatment of PNH Market Share by Country (2021-2026) Table 130. Asia-Pacific Treatment of PNH Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Treatment of PNH Market Share Forecast by Country (2027-2032) Table 132. Latin America Treatment of PNH Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 134. Latin America Treatment of PNH Sales Market Share by Country (2021-2026) Table 135. Latin America Treatment of PNH Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Treatment of PNH Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Treatment of PNH Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Treatment of PNH Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Treatment of PNH Market Share by Country (2021-2026) Table 140. Latin America Treatment of PNH Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Treatment of PNH Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Treatment of PNH Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Treatment of PNH Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Treatment of PNH Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Treatment of PNH Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Treatment of PNH Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Treatment of PNH Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Treatment of PNH Market Share by Country (2021-2026) Table 150. Middle East and Africa Treatment of PNH Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Treatment of PNH Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Treatment of PNH Distributors List Table 155. Treatment of PNH Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Treatment of PNH Image Figure 2. Global Treatment of PNH Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of PNH Market Size (2021-2032) & (US$ Million) Figure 4. Global Treatment of PNH Sales (2021-2032) & (K Units) Figure 5. Complement Inhibitors Image Figure 6. Global Complement Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Supportive Care Image Figure 8. Global Supportive Care Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Treatment of PNH Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Treatment of PNH Market Share by Type 2025 VS 2032 Figure 13. North America Treatment of PNH Sales Market Share in Volume by Type in 2025 Figure 14. North America Treatment of PNH Sales Market Share in Value by Type in 2025 Figure 15. Europe Treatment of PNH Sales Market Share in Volume by Type in 2025 Figure 16. Europe Treatment of PNH Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Treatment of PNH Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Treatment of PNH Sales Market Share in Value by Type in 2025 Figure 19. Latin America Treatment of PNH Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Treatment of PNH Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Treatment of PNH Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Treatment of PNH Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Treatment of PNH Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Treatment of PNH Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Treatment of PNH Market Share by Application 2025 VS 2032 Figure 33. North America Treatment of PNH Sales Market Share in Volume by Application in 2025 Figure 34. North America Treatment of PNH Sales Market Share in Value by Application in 2025 Figure 35. Europe Treatment of PNH Sales Market Share in Volume by Application in 2025 Figure 36. Europe Treatment of PNH Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Treatment of PNH Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Treatment of PNH Sales Market Share in Value by Application in 2025 Figure 39. Latin America Treatment of PNH Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Treatment of PNH Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Treatment of PNH Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Treatment of PNH Sales Market Share in Value by Application in 2025 Figure 43. North America Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Treatment of PNH Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Treatment of PNH Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Treatment of PNH Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Treatment of PNH Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Treatment of PNH Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Treatment of PNH Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Treatment of PNH Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Treatment of PNH Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Treatment of PNH Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Treatment of PNH Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Treatment of PNH Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Treatment of PNH Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Treatment of PNH Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Treatment of PNH Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Treatment of PNH Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Treatment of PNH Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Treatment of PNH Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Inhibitors
  • Supportive Care
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Alexion Pharmaceuticals
  • Apellis Pharmaceuticals
  • Samsung Bioepis
  • Amgen
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Treatment of PNH Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Treatment of PNH Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Treatment of PNH Market by Type
  6. 1.3.1 Complement Inhibitors
  7. 1.3.2 Supportive Care
  8. 1.3.3 Others
  9. 1.4 Global Treatment of PNH Market Size by Type
  10. 1.4.1 Global Treatment of PNH Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Treatment of PNH Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Treatment of PNH Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Treatment of PNH Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Treatment of PNH Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Treatment of PNH Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Treatment of PNH Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Treatment of PNH Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Treatment of PNH Industry Trends
  2. 2.2 Treatment of PNH Industry Drivers
  3. 2.3 Treatment of PNH Industry Opportunities and Challenges
  4. 2.4 Treatment of PNH Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Treatment of PNH Revenue (2021-2026)
  2. 3.2 Global Top Players by Treatment of PNH Sales (2021-2026)
  3. 3.3 Global Top Players by Treatment of PNH Price (2021-2026)
  4. 3.4 Global Treatment of PNH Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Treatment of PNH Major Company Production Sites & Headquarters
  6. 3.6 Global Treatment of PNH Company, Product Type & Application
  7. 3.7 Global Treatment of PNH Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Treatment of PNH Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Treatment of PNH Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Treatment of PNH Tier 1, Tier 2, and Tier 3
4 Treatment of PNH Regional Status and Outlook
  1. 4.1 Global Treatment of PNH Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Treatment of PNH Historic Market Size by Region
  3. 4.2.1 Global Treatment of PNH Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Treatment of PNH Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Treatment of PNH Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Treatment of PNH Forecasted Market Size by Region
  7. 4.3.1 Global Treatment of PNH Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Treatment of PNH Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Treatment of PNH Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Treatment of PNH by Application
  1. 5.1 Treatment of PNH Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Treatment of PNH Market Size by Application
  6. 5.2.1 Global Treatment of PNH Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Treatment of PNH Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Treatment of PNH Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Treatment of PNH Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Treatment of PNH Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Treatment of PNH Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Treatment of PNH Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Treatment of PNH Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alexion Pharmaceuticals
  2. 6.1.1 Alexion Pharmaceuticals Company Information
  3. 6.1.2 Alexion Pharmaceuticals Business Overview
  4. 6.1.3 Alexion Pharmaceuticals Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alexion Pharmaceuticals Treatment of PNH Product Portfolio
  6. 6.1.5 Alexion Pharmaceuticals Recent Developments
  7. 6.2 Apellis Pharmaceuticals
  8. 6.2.1 Apellis Pharmaceuticals Company Information
  9. 6.2.2 Apellis Pharmaceuticals Business Overview
  10. 6.2.3 Apellis Pharmaceuticals Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apellis Pharmaceuticals Treatment of PNH Product Portfolio
  12. 6.2.5 Apellis Pharmaceuticals Recent Developments
  13. 6.3 Samsung Bioepis
  14. 6.3.1 Samsung Bioepis Company Information
  15. 6.3.2 Samsung Bioepis Business Overview
  16. 6.3.3 Samsung Bioepis Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Samsung Bioepis Treatment of PNH Product Portfolio
  18. 6.3.5 Samsung Bioepis Recent Developments
  19. 6.4 Amgen
  20. 6.4.1 Amgen Company Information
  21. 6.4.2 Amgen Business Overview
  22. 6.4.3 Amgen Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Treatment of PNH Product Portfolio
  24. 6.4.5 Amgen Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Treatment of PNH Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Treatment of PNH Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Treatment of PNH Product Portfolio
  36. 6.6.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Treatment of PNH Sales by Country
  2. 7.1.1 North America Treatment of PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Treatment of PNH Sales by Country (2021-2026)
  4. 7.1.3 North America Treatment of PNH Sales Forecast by Country (2027-2032)
  5. 7.2 North America Treatment of PNH Market Size by Country
  6. 7.2.1 North America Treatment of PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Treatment of PNH Market Size by Country (2021-2026)
  8. 7.2.3 North America Treatment of PNH Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Treatment of PNH Sales by Country
  2. 8.1.1 Europe Treatment of PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Treatment of PNH Sales by Country (2021-2026)
  4. 8.1.3 Europe Treatment of PNH Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Treatment of PNH Market Size by Country
  6. 8.2.1 Europe Treatment of PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Treatment of PNH Market Size by Country (2021-2026)
  8. 8.2.3 Europe Treatment of PNH Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Treatment of PNH Sales by Country
  2. 9.1.1 Asia-Pacific Treatment of PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Treatment of PNH Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Treatment of PNH Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Treatment of PNH Market Size by Country
  6. 9.2.1 Asia-Pacific Treatment of PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Treatment of PNH Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Treatment of PNH Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Treatment of PNH Sales by Country
  2. 10.1.1 South America Treatment of PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Treatment of PNH Sales by Country (2021-2026)
  4. 10.1.3 South America Treatment of PNH Sales Forecast by Country (2027-2032)
  5. 10.2 South America Treatment of PNH Market Size by Country
  6. 10.2.1 South America Treatment of PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Treatment of PNH Market Size by Country (2021-2026)
  8. 10.2.3 South America Treatment of PNH Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Treatment of PNH Sales by Country
  2. 11.1.1 Middle East and Africa Treatment of PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Treatment of PNH Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Treatment of PNH Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Treatment of PNH Market Size by Country
  6. 11.2.1 Middle East and Africa Treatment of PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Treatment of PNH Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Treatment of PNH Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Treatment of PNH Value Chain Analysis
  2. 12.1.1 Treatment of PNH Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Treatment of PNH Production Mode & Process
  7. 12.2 Treatment of PNH Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Treatment of PNH Distributors
  10. 12.2.3 Treatment of PNH Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst